{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:28:34Z","timestamp":1794493714535,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008028","name":"School of Medicine and Public Health, University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008028","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Pathology, University of Wisconsin-Madison","id":[{"id":"https:\/\/ror.org\/01y2jtd41","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in metabolism, such as placing patients on a ketogenic diet, can alter cognition by an unknown mechanism. One of the ketone bodies produced as a result of ketogenesis, \u03b2-hydroxybutyrate (BHB), is known to inhibit NLRP3 inflammasome activation. Therefore, we tested if BHB inhibition of the NLRP3 inflammasome reduces overall AD pathology in the 5XFAD mouse model of AD. Here, we find BHB levels are lower in red blood cells and brain parenchyma of AD patients when compared with non-AD controls. Furthermore, exogenous BHB administration reduced plaque formation, microgliosis, apoptosis-associated speck-like protein containing a caspase recruitment domain (Asc) speck formation, and caspase-1 activation in the 5XFAD mouse model of AD. Taken together, our findings demonstrate that BHB reduces AD pathology by inhibiting NLRP3 inflammasome activation. Additionally, our data suggest dietary or pharmacological approaches to increase BHB levels as promising therapeutic strategies for AD.<\/jats:p>","DOI":"10.1186\/s12974-020-01948-5","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T10:04:04Z","timestamp":1600682644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":258,"title":["\u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology"],"prefix":"10.1186","volume":"17","author":[{"given":"Daniel C.","family":"Shippy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patel A.","family":"Viharkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Raife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6507-4989","authenticated-orcid":false,"given":"Tyler K.","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"1948_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119\u201328.","journal-title":"Lancet Neurol"},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM de la Monte","year":"2014","unstructured":"de la Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol. 2014;88:548\u201359.","journal-title":"Biochem Pharmacol"},{"key":"1948_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 maintains microglial metabolic fitness in Alzheimer's disease. Cell. 2017;170:649\u201363 e613.","journal-title":"Cell"},{"key":"1948_CR4","doi-asserted-by":"crossref","unstructured":"Gotzl JK, Brendel M, Werner G, Parhizkar S, Sebastian Monasor L, Kleinberger G, et al. Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. EMBO Mol Med. 2019;11.","DOI":"10.15252\/emmm.201809711"},{"key":"1948_CR5","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embj.201796516","volume":"36","author":"G Kleinberger","year":"2017","unstructured":"Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 2017;36:1837\u201353.","journal-title":"EMBO J"},{"key":"1948_CR6","first-page":"77sr71","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr71.","journal-title":"Sci Transl Med"},{"key":"1948_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"1948_CR8","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer's disease. J Clin Invest. 2017;127:3240\u20139.","journal-title":"J Clin Invest"},{"key":"1948_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"1948_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"1948_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"1948_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"1948_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"1948_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","volume":"25","author":"MA Reger","year":"2004","unstructured":"Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004;25:311\u20134.","journal-title":"Neurobiol Aging"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-7075-6-31","volume":"6","author":"ST Henderson","year":"2009","unstructured":"Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31.","journal-title":"Nutr Metab (Lond)"},{"key":"1948_CR16","doi-asserted-by":"publisher","first-page":"425 e419","DOI":"10.1016\/j.neurobiolaging.2010.10.006","volume":"33","author":"R Krikorian","year":"2012","unstructured":"Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012;33:425 e419\u201327.","journal-title":"Neurobiol Aging"},{"key":"1948_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trci.2017.11.002","volume":"4","author":"MK Taylor","year":"2018","unstructured":"Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:28\u201336.","journal-title":"Alzheimers Dement (N Y)"},{"key":"1948_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2018.10.048","volume":"690","author":"M Ota","year":"2019","unstructured":"Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease. Neurosci Lett. 2019;690:232\u20136.","journal-title":"Neurosci Lett"},{"key":"1948_CR19","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.neurobiolaging.2012.11.023","volume":"34","author":"Y Kashiwaya","year":"2013","unstructured":"Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR, et al. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging. 2013;34:1530\u20139.","journal-title":"Neurobiol Aging"},{"key":"1948_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.neurobiolaging.2014.10.003","volume":"36","author":"C Klein","year":"2015","unstructured":"Klein C, Mathis C, Leva G, Patte-Mensah C, Cassel JC, Maitre M, et al. Gamma-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease. Neurobiol Aging. 2015;36:832\u201344.","journal-title":"Neurobiol Aging"},{"key":"1948_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jnc.13958","volume":"141","author":"RJ Pawlosky","year":"2017","unstructured":"Pawlosky RJ, Kemper MF, Kashiwaya Y, King MT, Mattson MP, Veech RL. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease. J Neurochem. 2017;141:195\u2013207.","journal-title":"J Neurochem"},{"key":"1948_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263\u20139.","journal-title":"Nat Med"},{"key":"1948_CR23","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"1948_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11:718\u201326.","journal-title":"Alzheimers Dement"},{"key":"1948_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated A\u03b2 oligomers. J Clin Invest. 2012;122:1339\u201353.","journal-title":"J Clin Invest"},{"key":"1948_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316\u201338.","journal-title":"J Clin Invest"},{"key":"1948_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96:115\u201329 e115.","journal-title":"Neuron"},{"key":"1948_CR28","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.nbd.2019.104541","volume":"132","author":"B Kim","year":"2019","unstructured":"Kim B, Elzinga SE, Henn RE, McGinley LM, Feldman EL. The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease. Neurobiol Dis. 2019;132:104541.","journal-title":"Neurobiol Dis"},{"key":"1948_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11010-007-9448-z","volume":"302","author":"HM Dashti","year":"2007","unstructured":"Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007;302:249\u201356.","journal-title":"Mol Cell Biochem"},{"key":"1948_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1743-7075-5-36","volume":"5","author":"EC Westman","year":"2008","unstructured":"Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008;5:36.","journal-title":"Nutr Metab (Lond)"},{"key":"1948_CR31","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","volume":"97","author":"Y Kashiwaya","year":"2000","unstructured":"Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A. 2000;97:5440\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1948_CR32","doi-asserted-by":"publisher","first-page":"50A","DOI":"10.1016\/S0002-9149(97)00458-X","volume":"80","author":"Y Kashiwaya","year":"1997","unstructured":"Kashiwaya Y, King MT, Veech RL. Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am J Cardiol. 1997;80:50A\u201364A.","journal-title":"Am J Cardiol"},{"key":"1948_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0306-4522(00)00294-3","volume":"100","author":"K Pierre","year":"2000","unstructured":"Pierre K, Pellerin L, Debernardi R, Riederer BM, Magistretti PJ. Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy. Neuroscience. 2000;100:617\u201327.","journal-title":"Neuroscience"},{"key":"1948_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1014806723147","volume":"27","author":"L Bergersen","year":"2002","unstructured":"Bergersen L, Rafiki A, Ottersen OP. Immunogold cytochemistry identifies specialized membrane domains for monocarboxylate transport in the central nervous system. Neurochem Res. 2002;27:89\u201396.","journal-title":"Neurochem Res"},{"key":"1948_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1743-7075-2-28","volume":"2","author":"I Van der Auwera","year":"2005","unstructured":"Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond). 2005;2:28.","journal-title":"Nutr Metab (Lond)"},{"key":"1948_CR36","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","volume":"93","author":"M Hoshi","year":"1996","unstructured":"Hoshi M, Takashima A, Noguchi K, Murayama M, Sato M, Kondo S, et al. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci U S A. 1996;93:2719\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1948_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1096\/fasebj.9.8.7768357","volume":"9","author":"K Sato","year":"1995","unstructured":"Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 1995;9:651\u20138.","journal-title":"FASEB J"},{"key":"1948_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021788","volume":"6","author":"J Yao","year":"2011","unstructured":"Yao J, Chen S, Mao Z, Cadenas E, Brinton RD. 2-deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS One. 2011;6:e21788.","journal-title":"PLoS One"},{"key":"1948_CR39","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2009;106:14670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1948_CR40","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b2 42 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"key":"1948_CR41","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med. 2015;3:136.","journal-title":"Ann Transl Med"},{"key":"1948_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease. Mol Neurodegener. 2018;13:11.","journal-title":"Mol Neurodegener"},{"key":"1948_CR43","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/glia.23046","volume":"64","author":"A Sierra","year":"2016","unstructured":"Sierra A, de Castro F, Del Rio-Hortega J, Rafael Iglesias-Rozas J, Garrosa M, Kettenmann H. The \"big-bang\" for modern glial biology: translation and comments on Pio del Rio-Hortega 1919 series of papers on microglia. Glia. 2016;64:1801\u201340.","journal-title":"Glia"},{"key":"1948_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014;10:217\u201324.","journal-title":"Nat Rev Neurol"},{"key":"1948_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/bpa.12456","volume":"27","author":"DS Davies","year":"2017","unstructured":"Davies DS, Ma J, Jegathees T, Goldsbury C. Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease. Brain Pathol. 2017;27:795\u2013808.","journal-title":"Brain Pathol"},{"key":"1948_CR46","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/acel.12210","volume":"13","author":"R Baron","year":"2014","unstructured":"Baron R, Babcock AA, Nemirovsky A, Finsen B, Monsonego A. Accelerated microglial pathology is associated with A\u03b2 plaques in mouse models of Alzheimer's disease. Aging Cell. 2014;13:584\u201395.","journal-title":"Aging Cell"},{"key":"1948_CR47","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","volume":"28","author":"T Bolmont","year":"2008","unstructured":"Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, et al. Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance. J Neurosci. 2008;28:4283\u201392.","journal-title":"J Neurosci"},{"key":"1948_CR48","doi-asserted-by":"publisher","first-page":"14156","DOI":"10.1523\/JNEUROSCI.4147-08.2008","volume":"28","author":"J Koenigsknecht-Talboo","year":"2008","unstructured":"Koenigsknecht-Talboo J, Meyer-Luehmann M, Parsadanian M, Garcia-Alloza M, Finn MB, Hyman BT, et al. Rapid microglial response around amyloid pathology after systemic anti- A\u03b2 antibody administration in PDAPP mice. J Neurosci. 2008;28:14156\u201364.","journal-title":"J Neurosci"},{"key":"1948_CR49","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387\u201394.","journal-title":"Nat Neurosci"},{"key":"1948_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ni.1703","volume":"10","author":"L Franchi","year":"2009","unstructured":"Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10:241\u20137.","journal-title":"Nat Immunol"},{"key":"1948_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11481-017-9754-5","volume":"12","author":"V Deora","year":"2017","unstructured":"Deora V, Albornoz EA, Zhu K, Woodruff TM, Gordon R. The ketone body beta-hydroxybutyrate does not inhibit synuclein mediated inflammasome activation in microglia. J NeuroImmune Pharmacol. 2017;12:568\u201374.","journal-title":"J NeuroImmune Pharmacol"},{"key":"1948_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"1948_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12871-020-0943-z","volume":"20","author":"Z Kovacs","year":"2020","unstructured":"Kovacs Z, Brunner B, D'Agostino DP, Ari C. Inhibition of adenosine A1 receptors abolished the nutritional ketosis-evoked delay in the onset of isoflurane-induced anesthesia in Wistar albino Glaxo Rijswijk rats. BMC Anesthesiol. 2020;20:30.","journal-title":"BMC Anesthesiol"},{"key":"1948_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnmol.2017.00235","volume":"10","author":"Z Kovacs","year":"2017","unstructured":"Kovacs Z, D'Agostino DP, Dobolyi A, Ari C. Adenosine A1 receptor antagonism abolished the anti-seizure effects of exogenous ketone supplementation in Wistar albino Glaxo Rijswijk rats. Front Mol Neurosci. 2017;10:235.","journal-title":"Front Mol Neurosci"},{"key":"1948_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12986-017-0184-4","volume":"14","author":"RO Caminhotto","year":"2017","unstructured":"Caminhotto RO, Komino ACM, de Fatima SF, Andreotti S, Sertie RAL, Boltes Reis G, et al. Oral beta-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats. Nutr Metab (Lond). 2017;14:31.","journal-title":"Nutr Metab (Lond)"},{"key":"1948_CR56","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"1948_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1948_CR58","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01948-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01948-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01948-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T19:22:51Z","timestamp":1632165771000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01948-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01948-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}